Ivacaftor is prescribed for the treatment of cystic fibrosis. It is specifically designed to treat adults and children as young as six years old who have specific gene mutations. This medication comes as a tablet that is taken once or twice daily, or twice a week, depending on various factors. Throat pain and headaches are some of the commonly reported side effects.
What Is Ivacaftor?
Ivacaftor (Kalydeco™) is a prescription medication approved for the treatment of cystic fibrosis. Specifically, it is approved for use in adults and children as young as 6 years old who have certain mutations of the CF gene.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 21, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click